AdvisorShares Investments’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.84M Buy
7,318
+3,153
+76% +$678K 0.22% 58
2026
Q1
$906K Buy
4,165
+1,222
+42% +$271K 0.17% 88
2025
Q4
$672K Buy
+2,943
New +$670K 0.11% 99
2020
Q4
Sell
-4,842
Closed -$424K 143
2020
Q3
$424K Sell
4,842
-1,343
-22% -$126K 0.02% 99
2020
Q2
$607K Sell
6,185
-772
-11% -$68K 0.26% 83
2020
Q1
$530K Sell
6,957
-387
-5% -$33K 0.46% 50
2019
Q4
$650K Buy
+7,344
New +$610K 0.4% 97

Other funds holding ABBV

AdvisorShares Investments's ABBV Position: Q2 2026 in Review

AdvisorShares Investments increased its AbbVie (ABBV) stake by 76% in Q2 2026, buying an estimated $678K and bringing the position to 7,318 shares worth $1.84M. The position accounts for 0.22% of the portfolio, ranked #58.

AdvisorShares Investments first reported a position in ABBV in Q4 2019 and has held it in 7 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • AdvisorShares Investments held 7,318 shares of AbbVie worth $1.84M as of Q2 2026.
  • AdvisorShares Investments bought 3,153 AbbVie shares in Q2 2026, an estimated $678K.
  • AbbVie made up 0.22% of AdvisorShares Investments's portfolio in Q2 2026, its #58 holding.
  • AdvisorShares Investments first reported a position in AbbVie in Q4 2019 and has held it in 7 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on AdvisorShares Investments's 13F filing for Q2 2026, filed 11 Aug 2026.